BioElectronics Corporation
BIEL
$0.0001
-$0.0001-50.00%
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | |
|---|---|---|---|---|---|
| Net Income | 75.00% | 82.14% | 68.64% | 57.99% | 50.13% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -40.12% | -64.77% | -21.88% | -35.18% | -56.64% |
| Change in Net Operating Assets | -229.41% | -221.83% | -124.47% | -125.02% | -66.78% |
| Cash from Operations | 39.34% | 19.38% | 54.73% | 11.45% | 26.23% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -36.64% | -21.94% | -29.66% | -9.80% | -11.20% |
| Total Debt Repaid | -45.29% | 88.17% | 64.22% | 61.94% | 50.35% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 14.58% | -- | -- | -- | -- |
| Cash from Financing | -64.22% | -15.27% | -46.62% | -6.49% | -11.59% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -271.72% | 453.70% | 818.06% | 103.71% | 235.55% |
